Colorectal Cancer Diagnostics and Therapeutics Market - By Diagnostics Techniques (Stool Tests, Immunohistochemistry, Colonoscopy, Flexible Sigmoidoscopy, Other Diagnostics Techniques) By Solution (Therapeutics, Chemotherapy, Antimetabolites, Fluorouracil, Capecitabine, Alkylating Agent Oxaliplatin, Immunotherapy, Bevacizumab, Cetuximab, Panitumumab, Chemoprotectant, Other Chemotherapeutic Agents) By Region (North America, Europe, Asia Pacific, Middle East & Africa, Rest of the World) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 183
Status: Published
Report Code: ARI100827
With the increasing cost of cancer drugs the global colorectal cancer diagnostics and therapeutics market is facing crucial challenges in the growth of the market. Moreover, due to the loss of patients with cancer drugs, the demand for global colorectal cancer diagnostics and therapeutics market is expected to hamper the growth.
In the recent past, the global colorectal cancer diagnostics and therapeutics market has witnessed a drastic change owing to the introduction of Bevacizumab which is a monoclonal antibody that allows tumors from increasing blood vessels. This helps cure tumors and generate new blood vessel formation. The FDA has approved an extension for bevacizumab. This is an amalgamation with intravenous 5-fluorouracil-based chemotherapy and metastatic carcinoma of the rectum and colon. Thus, this boosts the global colorectal cancer diagnostics and therapeutics market.
In terms of market players, the global colorectal cancer diagnostics and therapeutics market is competitive and fragmented with the presence of various kinds of different vendors including Abbott Laboratories, Beckman Coulter, Clinical Genomics, Companion DX, EDP Biotech, Epigenomics AG, F. Hoffmann-La Roche AG, Novigenix, Quest Diagnostics, Siemens Healthineers, and VolitionRX, among others.
Analyst Commentary
Colorectal cancer holds one of the largest incidences and prevalence rates across the globe. Moreover, the primary cause of colorectal cancer can be ageing, a healthy diet, and routine lifestyle. It has been noticed that according to the World Health Organization (WHO) with an increase of 70% the colorectal cancer cases are expected to report by 2030. Thus, increasing prevalence rates and increasing incidences are considered as the major factors influencing the global colorectal cancer diagnostics and therapeutics market.
Colorectal cancer is considered as the second most cause of cancer with the highest death rate in the United States. Colorectal cancer is expected to register over 9% of cases from all cancer incidences and is believed to be a significant cause of mortality across the globe. However, this increases demands for the global colorectal cancer diagnostics and therapeutics market with tremendous growth.
Due to the steady growth, the industry is planning for the expansion of services programs for research and development of colorectal cancer diagnostics solutions to be prepared for the battle-ground communication systems. This boosts the growth of the global colorectal cancer diagnostics and therapeutics market in the coming years. The leading companies in the global colorectal cancer diagnostics and therapeutics market are planning strategies such as joint ventures to generate long-term profits, acquisitions, and strengthen the product assortment.
Segmentation
The global colorectal cancer diagnostics and therapeutics market is categorized into several segmentations including diagnostics techniques overview, modality overview, service overview, security type, deployment type, organization size, vertical industry, and regions. Based on the diagnostics techniques overview, the global colorectal cancer diagnostics and therapeutics market is fragmented into Stool Tests, Immunohistochemistry, Colonoscopy, Flexible Sigmoidoscopy, and Other Diagnostics Techniques. Based on the modality overview, the global colorectal cancer diagnostics and therapeutics market is segregated into Therapeutics, Chemotherapy, Antimetabolites, Fluorouracil, Capecitabine, Alkylating Agent Oxaliplatin, Immunotherapy, Bevacizumab, Cetuximab, Panitumumab, Chemoprotectant, and Other Chemotherapeutic Agents. The modality segment is about to project faster growth along with tremendous popularity in the market owing to the increasing population of towards colorectal cancer and increasing government initiatives for people suffering from colorectal cancer therapeutics the demand for global colorectal cancer diagnostics and therapeutics market is expected to witness lucrative growth over the forecast period.
Regional Analysis:
Based on region, the global colorectal cancer diagnostics and therapeutics market is widespread to the Middle East and Africa, Egypt, Saudi Arabia, Canada, South Africa, Asia Pacific, Argentina, Mexico, Korea, India, France, Turkey, Nigeria, UAE, Europe, Japan, China, UK, Russia, South America, Brazil, Italy, North America, Southeast Asia, Germany, USA, and Columbia.
North America is anticipated to hold the largest market size in the colorectal cancer diagnostics and therapeutics market, followed by Europe. This is due to the increasing presence of key vendors in the region. Furthermore, Europe is expected to hold the highest market size in the market resulting in GDPR compliance. Due to the increasing technological advancement in Asia Pacific region, the factors influencing the colorectal cancer diagnostics and therapeutics market include increasing prevalence of cancer therapies, growing number of colorectal cancer screening tests such as sigmoidoscopy, biopsy, CT colonography, and double-contrast barium enema are expected to project lucrative growth over the forecast period.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Colorectal Cancer Diagnostics and Therapeutics Market
Chapter 5. Global Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 – 2027 (USD Million)
5.1. Global Colorectal Cancer Diagnostics and Therapeutics Market Share, By Diagnostics Techniques, 2020 & 2027 (%)
5.1.1. Stool Tests
5.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.2. Immunohistochemistry
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.3. Colonoscopy
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.4. Flexible Sigmoidoscopy
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.5. Other Diagnostics Techniques
5.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 6. Global Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 – 2027 (USD Million)
6.1. Global Colorectal Cancer Diagnostics and Therapeutics Market Share, By Solution, 2020 & 2027 (%)
6.1.1. Therapeutics
6.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.2. Chemotherapy
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.3. Antimetabolites
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.4. Fluorouracil
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.5. Capecitabine
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.6. Alkylating Agent Oxaliplatin
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.7. Immunotherapy
6.1.7.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.7.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.8. Bevacizumab
6.1.8.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.8.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.9. Cetuximab
6.1.9.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.9.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.10. Panitumumab
6.1.10.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.10.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.11. Chemoprotectant
6.1.11.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.11.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.12. Other Chemotherapeutic Agents
6.1.12.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.12.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 7. Global Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Geography, 2015 - 2027 (USD Million)
7.1. Global Colorectal Cancer Diagnostics and Therapeutics Market Share, By Geography, 2015 - 2027(USD Million)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 (%)
Chapter 8. North America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
8.1. North America Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2020 & 2027 (%)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
8.1.3. North America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
8.1.4. North America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027 (USD Million)
8.1.4.2. Canada Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027 (USD Million)
Chapter 9. Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2020 & 2027 (%)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027 (USD Million)
9.1.3. Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027 (USD Million)
9.1.4. Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027 (USD Million)
9.1.4.1.3. Germany Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027 (USD Million)
9.1.4.1.4. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.5. France Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
9.1.4.1.6. France Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
9.1.4.2. UK
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. UK Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
9.1.4.2.3. UK Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
9.1.4.3. Italy
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. Italy Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
9.1.4.3.3. Italy Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
9.1.4.4. Spain
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Spain Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
9.1.4.4.3. Spain Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
9.1.4.5. Rest of Europe
9.1.4.5.1. Market size and projections, 2015 – 2025
9.1.4.5.2. Rest of Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
9.1.4.5.3. Rest of Europe Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
Chapter 10. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2020 & 2027(%)
10.1.1. Market size and projections, 2015 - 2027(USD Million)
10.1.2. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
10.1.3. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
10.1.4. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.1.2. India Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
10.1.4.1.3. India Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.2.2. China Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
10.1.4.2.3. China Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.3.2. Japan Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
10.1.4.3.3. Japan Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.4.2. South Korea Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
10.1.4.4.3. South Korea Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027(USD Million)
10.1.4.5.2. Rest of Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
10.1.4.5.3. Rest of Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
Chapter 11. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2015 - 2027(USD Million)
11.1.1. Market size and projections, 2015 - 2027(USD Million)
11.1.2. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
11.1.3. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
11.1.4. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027(USD Million)
11.1.4.1.2. GCC Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
11.1.4.1.3. GCC Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
11.1.4.1.4. Market size and projections, 2015 - 2027(USD Million)
11.1.4.1.5. South Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
11.1.4.1.6. South Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
11.1.4.2. Rest of Middle East & Africa
11.1.4.2.1. Market size and projections, 2015 - 2027(USD Million)
11.1.4.2.2. Rest of Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
Chapter 12. South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015 - 2027(USD Million)
12.1. South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, 2015 - 2027(USD Million)
12.1.1. Market size and projections, 2015 - 2027(USD Million)
12.1.2. South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
12.1.3. South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
12.1.4. South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Countries, 2015- 2026(USD Million)
12.1.5. Brazil
12.1.5.1. Market size and projections, 2015 - 2027(USD Million)
12.1.5.2. Brazil Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
12.1.5.3. Brazil Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
12.1.6. Argentina
12.1.6.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.2. Argentina Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
12.1.6.3. Argentina Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
12.1.7. Rest of South America
12.1.7.1. Market size and projections, 2015 – 2027
12.1.7.2. Rest of South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Diagnostics Techniques, 2015 - 2027(USD Million)
12.1.7.3. Rest of South America Colorectal Cancer Diagnostics and Therapeutics Market Overview, By Solution, 2015 - 2027(USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New product development
Chapter 14. Key Vendor Analysis
14.1. Abbott Laboratories
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Clinical Genomics Technologies Pty Ltd
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Bruker Corporation
14.4. EDP Biotech Corporation
14.5. Novigenix SA
14.6. Others
Chapter 15. Colorectal Cancer Diagnostics and Therapeutics Market Cost Analysis
15.1. Key Raw Materials Analysis
15.1.1. Key Raw Materials
15.1.2. Price Trend of Colorectal Cancer Diagnostics and Therapeutics Market Key Raw Materials
15.1.3. Key Suppliers of Raw Materials
15.1.4. Market Concentration Rate of Raw Materials
Chapter 16. Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1. Industrial Chain Analysis
16.2. Upstream Raw Materials Sourcing
16.3. Raw Materials Sources of Colorectal Cancer Diagnostics and Therapeutics Market Major Manufacturers in 2020
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Industry
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Colorectal Cancer Diagnostics and Therapeutics Market share, By Diagnostics Techniques, 2020 & 2027 (%)
10. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Stool Tests, By Diagnostics Techniques, 2015 - 2027(USD Million)
11. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Immunohistochemistry, By Diagnostics Techniques, 2015 - 2027(USD Million)
12. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Colonoscopy, By Diagnostics Techniques, 2015 - 2027(USD Million)
13. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Flexible Sigmoidoscopy, By Diagnostics Techniques, 2015 - 2027(USD Million)
14. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Other Diagnostics Techniques, By Diagnostics Techniques, 2015 - 2027(USD Million)
15. Global Colorectal Cancer Diagnostics and Therapeutics Market share, By Solution, 2020 & 2027 (%)
16. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Therapeutics, By Solution, 2015 - 2027(USD Million)
17. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Chemotherapy, By Solution, 2015 - 2027(USD Million)
18. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Antimetabolites, By Solution, 2015 - 2027(USD Million)
19. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Fluorouracil, By Solution, 2015 - 2027(USD Million)
20. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Capecitabine, By Solution, 2015 - 2027(USD Million)
21. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Alkylating Agent Oxaliplatin, By Solution, 2015 - 2027(USD Million)
22. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Immunotherapy, By Solution, 2015 - 2027(USD Million)
23. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Bevacizumab, By Solution, 2015 - 2027(USD Million)
24. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Cetuximab, By Solution, 2015 - 2027(USD Million)
25. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Panitumumab, By Solution, 2015 - 2027(USD Million)
26. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Chemoprotectant, By Solution, 2015 - 2027(USD Million)
27. Global Colorectal Cancer Diagnostics and Therapeutics Market, by Other Chemotherapeutic Agents, By Solution, 2015 - 2027(USD Million)
28. Global Colorectal Cancer Diagnostics and Therapeutics Market share, by region, 2020 & 2027 (%)
29. North America Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
30. North America Colorectal Cancer Diagnostics and Therapeutics Market share, by Countries, 2020 & 2027 (%)
31. U.S. Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
32. Canada Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
33. Europe Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
34. Europe Colorectal Cancer Diagnostics and Therapeutics Market share, by Countries, 2020 & 2027 (%)
35. Spain Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
36. UK Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
37. Italy Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
38. Germany Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
39. France Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
40. Rest of Europe Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
41. Asia-Pacific Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
42. Asia-Pacific Colorectal Cancer Diagnostics and Therapeutics Market share, by Countries, 2020 & 2027 (%)
43. China Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
44. India Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
45. Australia Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
46. Japan Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
47. Rest of Asia-Pacific Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
48. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
49. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market share, by Countries, 2020 & 2027 (%)
50. GCC Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
51. South Africa Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
52. Rest Of Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
53. South America Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
54. Brazil Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
55. Mexico Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
56. Argentina Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
57. Rest of South America Colorectal Cancer Diagnostics and Therapeutics Market, 2020 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Colorectal Cancer Diagnostics and Therapeutics Market, 2015-2027(USD Million)
4. Global Colorectal Cancer Diagnostics and Therapeutics Market requirement, by country, 2015-2027,(USD Million)
5. North America Colorectal Cancer Diagnostics and Therapeutics Market, By Diagnostics Techniques, 2015-2027(USD Million)
6. North America Colorectal Cancer Diagnostics and Therapeutics Market, By Solution, 2015-2027(USD Million)
7. Europe Colorectal Cancer Diagnostics and Therapeutics Market, By Diagnostics Techniques, 2015-2027(USD Million)
8. Europe Colorectal Cancer Diagnostics and Therapeutics Market, By Solution, 2015-2027(USD Million)
9. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market, By Diagnostics Techniques, 2015-2027(USD Million)
10. Asia Pacific Colorectal Cancer Diagnostics and Therapeutics Market, By Solution, 2015-2027(USD Million)
11. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market, By Diagnostics Techniques, 2015-2027(USD Million)
12. Middle East & Africa Colorectal Cancer Diagnostics and Therapeutics Market, By Solution, 2015-2027(USD Million)
13. South America Colorectal Cancer Diagnostics and Therapeutics Market, By Diagnostics Techniques, 2015-2027(USD Million)
14. South America Colorectal Cancer Diagnostics and Therapeutics Market, By Solution, 2015-2027(USD Million)
15. Global Colorectal Cancer Diagnostics and Therapeutics Market, Company Market Share, 2020 (%)
16. Abbott Laboratories: Product Benchmarking
17. Abbott Laboratories: Financial Performance
18. Clinical Genomics Technologies Pty Ltd: Product Benchmarking
19. Clinical Genomics Technologies Pty Ltd: Financial Performance
20. Bruker Corporation: Product Benchmarking
21. Bruker Corporation: Financial Performance
22. EDP Biotech Corporation: Product Benchmarking
23. EDP Biotech Corporation: Financial Performance
24. Novigenix SA: Product Benchmarking
25. Novigenix SA: Financial Performance
The Leading Key Players in Colorectal Cancer Diagnostics And Therapeutics Market
Abbott Laboratories
Beckman Coulter
Clinical Genomics
Companion DX
EDP Biotech
Epigenomics AG
F. Hoffmann-La Roche AG
Novigenix
Quest Diagnostics
Siemens Healthineers
VolitionRX,
